Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Counter Culture Ventures (CCV) is a venture capital firm focused on addressing misaligned incentives within the venture capital ecosystem. Founded to support equity-driven technologies, CCV has a portfolio of 8 companies and invests primarily in pre-seed, seed, and seed-plus stages. The firm emphasizes backing innovative founders who are committed to fundamentally changing how problems are perceived and resolved.
CCV invests in early-stage companies across sectors such as AI, healthcare, consumer, logistics, and energy. The firm typically backs maverick founders who challenge the status quo, with a particular emphasis on technologies that promote equity through Generative AI. Investment sizes are not specified, but the focus is on transformative solutions that address real-world challenges.
Notable portfolio companies include Hypelab, a privacy-compliant ad network; Syntracts, which accelerates document analysis; Positron, developing AI chips for efficient GPT inferencing; Whyhow, enhancing LLMs for business challenges; Waterlily, aiding elderly care planning; Dr. B, providing affordable medical consultations; Cytronic, operating automated warehouses; and Stealth, using AI for sustainable energy sourcing.
CCV typically participates in early-stage funding rounds, but specific details on leading rounds are not provided.
Information on follow-on investments is not explicitly mentioned in the available data.
The size of CCV's current fund is not disclosed in the source material.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.